Article

A potent synthetic nanobody targets RBD and protects mice from SARS-CoV-2 infection

Research square · 2020 · Tingting Li, author Hongmin Cai, author Hebang Yao, author Bingjie Zhou, author Ning Zhang, author Yuhuan Gong, author Yapei Zhao, author Quan Shen, author Wenming Qin, author Cedric A.J. Hutter, author Yanling Lai, author Shu-Ming Kuo, author Juan Bao, author Jiaming Lan, author Markus A. Seeger, author Gary Wong, author Yuhai Bi, author Dimitri Lavillette, author Dianfan Li, author

Key facts

Title A potent synthetic nanobody targets RBD and protects mice from SARS-CoV-2 infection
First author Tingting Li, author Hongmin Cai, author Hebang Yao, author Bingjie Zhou, author Ning Zhang, author Yuhuan Gong, author Yapei Zhao, author Quan Shen, author Wenming Qin, author Cedric A.J. Hutter, author Yanling Lai, author Shu-Ming Kuo, author Juan Bao, author Jiaming Lan, author Markus A. Seeger, author Gary Wong, author Yuhai Bi, author Dimitri Lavillette, author Dianfan Li, author
Journal Research square
Published Oct 30, 2020
DOI 10.21203/rs.3.rs-75540/v1
Devices mentioned 063011, K042152, K940422, K982100
Product codes mentioned CFN, DFZ

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature